Retatrutide is an investigational triple agonist developed by Eli Lilly that targets GLP-1, GIP and glucagon receptors, and early trials suggest very strong ...
Establishments using a U.S.-origin claim on FSIS-regulated products will need to provide access to documentation ...
Medically reviewed by Kristie Reed, PharmD Magnesium and potassium are important for muscle contraction, heart rhythms, and ...
Rhythm Pharmaceuticals is rated a Buy, driven by progress in HO, PWS, and oral MC4R agonists. Click here to read my latest ...
Establishments using US-origin claims will need to demonstrate the product meets regulatory requirements, effective Jan. 1.
More recently, the FDA posted two two letters: one backdated for September 9, regarding GSK’s HIV medication Apretude and one ...
FDA's new guidance clarifies promotional practices for biosimilars, ensuring accurate marketing and preventing misleading ...
" It sounds wholesome, right? Pure. Like something your grandmother might have used in her kitchen. The clean label movement has exploded in recent years, with half of industry professionals ...